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1Abstract
The presence of oligomeric aggregates, which is often observed during the process of amyloid
formation, has recently attracted much attention since it has been associated with neurode-
generative conditions such as Alzheimer’s and Parkinson’s diseases. We provide a descrip-
tion of a sequence-indepedent mechanism by which polypeptide chains aggregate by form-
ing metastable oligomeric intermediate states prior to converting into fibrillar structures. Our
results illustrate how the formation of ordered arrays of hydrogen bonds drives the forma-
tion of β-sheets within the disordered oligomeric aggregates that form early under the effect
of hydrophobic forces. Initially individual β-sheets form with random orientations, which
subsequently tend to align into protofilaments as their lengths increases. Our results suggest
that amyloid aggregation represents an example of the Ostwald step rule of first order phase
transitions by showing that ordered cross-β structures emerge preferentially from disordered
compact dynamical intermediate assemblies.
Author Summary
Considerable efforts are currently devoted to the study of the phenomenon of protein aggre-
gation because of its association with a range of human diseases and of its potential applica-
tions in biotechnology. Despite intense scrutiny, however, it has been extremely challenging
so far to characterise the intermediate phases of the aggregation process, during which disor-
dered oligomeric assemblies are formed. In our work, we have used molecular simulations
to show that the development of ordered structures within the initially disordered aggregates
is a consequence of the interplay between hydrophobicity and hydrogen bonding, which re-
sults in a behaviour typical of many first order condensation phenomena in material science.
These results provide further insight into the consequences of the “generic hypothesis” of
protein aggregation, according to which the ability to assemble into ordered cross-β struc-
tures is not an unusual feature exhibited by a small group of peptides and proteins with
special sequence or structural properties, but it is an inherent characteristic of polypeptide
chains.
2Introduction
A variety of peptides and proteins unrelated in sequence and structure have been shown to
convert into large ordered aggregates known as amyloid fibrils.1, 2 These structures share a
common cross-β structure formed by intertwined layers of β-sheets extending in a direction
parallel to the fibril axis.1, 3 The ubiquity of this type of assemblies has led to the sugges-
tion that they may represent a general structural state of polypeptide chains, which is ac-
cessible independently from their specific amino acid sequences.4 According to this view, if
placed under appropriate conditions, peptides and proteins can revert to the amyloid state,
which has been associated with a range of pathological conditions including Alzheimer’s
and Parkinson’s diseases.1, 5, 6
Small oligomeric aggregates are often found as precursors of amyloid fibrils,7–9 and their
formation in some cases may originate from a competition between amorphous and fibrillar
aggregation. The role of these molecular species in the process of amyloid fibril formation is
at present unclear, although much interest has been recently devoted to this problem since
their presence has been linked to neurodegenerative processes.8, 10 It has been suggested that,
under conditions that favor amyloid fibril formation, proteins or peptides within these dis-
ordered aggregates can convert into conformations capable of forming nuclei that give rise
to amyloid fibril assemblies.9 It has been, however, extremely challenging to characterize ex-
perimentally the structures of these aggregates and the mechanism of their formation owing
to their heterogeneous and dynamical nature.
In this work we consider the problem from a theoretical perspective and use computer
simulations to describe the process of condensation of polypeptide chains into oligomeric as-
semblies that further reorganise into fibrillar structures. The level of detail in which protein
aggregation can be investigated depends on the choice of the model. Full-atomistic simula-
tions have provided considerable insight into the dynamics of inter-molecular interactions in
systems containing a small number of peptides and short timescales.11–16 Complementary to
these approaches, coarse-grained models have proven capable of simulating larger systems
and longer timescales, and of following the structure of the oligomeric intermediates and
the mechanism of their conversion into ordered cross-β assemblies.17–21 Despite much recent
work in this area, many questions about the amyloid aggregation remain open, and here we
investigate the general properties of the mechanism of emergence and alignment of β-sheets
in the early stages of the oligomerization process. Given the close link between this phase
of amyloid formation and the neurotoxicity of the structural species involved,1, 8, 10, 22 we in-
vestigated here the competition between ordered and disordered aggregation of polypeptide
chains.
By following the hypothesis that amyloid formation represents a generic property of a
polypeptide chain,4 we adopt a recently proposed representation of the structure of polypep-
tide chains, known as the tube model,23–25 which enables a description of the free energy
3landscapes for folding23–25 and for aggregation26 to be obtained within a unified framework.
Since this model only includes interactions common to all polypeptide chains independently
from their amino acid sequence, it is ideally suited for exploring the consequences of the
generic hypothesis of amyloid formation. The characteristic features of the model23 are that
the protein backbone is assigned a finite thickness to account for excluded volume effects.
Residues interact with each other by pairwise additive hydrophobic forces (with energy eW ),
geometrical constraints apply to the formation of intra- and intermolecular hydrogen bonds
(with energy eHB), and the polypeptide chain experiences a local bending stiffness (with
energy eS).
Results
In this work we consider a system containing 216 12-residue homopolymers that exibit an α-
helical native state below the folding temperature (T ∗f ∼ 0.58) and an undfolded structure at
higher temperatures (see Methods). Peptides that form native α-helical conformations,27 as
well as homopolymeric sequences,28 have been shown to be able to form amyloid assemblies.
In order to investigate the self-assembly of the peptides into fibrils we chose thermodynamic
conditions such that fibril formation occurs on a timescale accessible to our simulations. We
found that a peptide concentration c = 12.5mM is above the critical concentration for ag-
gregation, provided that the temperature T ∗ < 0.69. All our simulations were performed at
T ∗ = 0.66, and several independent starting configurations were generated at T ∗ = 0.75. As
in our simulations we set T ∗ > T ∗f , the peptides were unfolded most of the time. A typical
trajectory observed in our Monte Carlo simulations (see Methods) is illustrated in Fig. 1.
We systematically observed a rapid collapse of the peptides into disordered aggregates
that subsequently underwent a structural reorganization and transform into cross-β protofil-
aments (Fig. 1). These results are consistent with a previously described two-step condensation-
ordering mechanism,16, 17, 26 which has also been observed experimentally.9 A plot of the to-
tal energy per peptide as a function of the progress variable t (Fig. 2) shows that the final
structure has a much lower energy than the initial and intermediate states. The major con-
tribution to this energy comes from hydrogen bonding (Fig. 2), a result consistent with the
recent report that the hydrogen bonding energy provides the dominant factor stabilising the
cross-β architecture is represented by hydrogen bonding, while in more disordered states
other contributions are also important.29 The initial state (t < 1000), before the hydrophobic
collapse, in which all peptides are solvated, has the highest energy and it is unstable. After
the hydrophobic collapse has taken place (1000 < t < 5000), the peptides form a disordered
oligomer, which is characterised by similar contributions from hydrophobic interactions and
hydrogen bonding (Fig. 2); this oligomeric state is lower in energy but metastable with re-
spect to the amyloid state. Finally, with the growth of the cross-β architecture the hydrogen
4bonding interactions become progressively dominant (Fig. 2). The survival time of the dis-
ordered oligomeric state is rather short (about 10-15% of the total simulation time) since in
order to be able to investigate the self-assembly of the peptides we chose thermodynamic
conditions such that the nucleation barriers associated with oligomer formation and the sub-
sequent ordering are readily overcome by thermal fluctuations. The height of the nucleation
barriers, and the associated lag times depend strongly on the thermodynamic conditions of
the system.26
In order to provide a detailed description of the emergence of cross-β protofilaments
within the oligomers, including their interactions and relative orientations with respect to
each other, we defined the oligomeric state using a distance criterion that requires the centres
of mass of two peptides to have a distance of less than 5A˚. Two peptide chains are taken
to form a β-sheet if they have more than four inter-chain hydrogen bonds with each other.
To define an angle between different β-sheets we calculated the relative orientation between
neighboring peptides that constitute the different β-sheet. Therefore we calculate the dot
product of the end to end vectors of the peptide molecules, requiring that the centres of mass
of two peptides are separated by less than 10A˚, which is the typical inter-sheet contact dis-
tance in most native and amyloid systems. If the average angle between two β-strands is less
than 20 degree, we assume that the respective β-sheets belong to the same protofilament.
In the example illustrated in Fig. 1, the initial stages of the process are characterized by the
formation within the disordered oligomer of six small β-sheets which are randomly oriented
with respect to each other (Fig. 3a). Subsequently, the β-sheets tend to align as their lengths
increase, and protofilaments consisting of one, three and four β-sheets are formed (Fig. 3b-d).
The two major protofilaments observed in this simulation seem to twist around each other
(Fig. 1 right panel), resembling the typical behavior observed experimentally.1 The twisting
appears to follow from the growth and alignment of β-sheets, which is a consequence of the
tendency to optimize the number of hydrophobic contacts, thereby reducing the interfacial
energy,30 and not from the chirality of the peptides, as the latter is not included in the tube
model used in this work. As the peptides within the oligomer can move only locally our
Monte Carlo dynamics should at least qualitatively resemble their actual dynamics.
We generated and analyzed a total of 11 independent trajectories, which consistently ap-
peared as the type shown in Fig. 1, and showed the same quantitative overall behavior. As-
semblies are initially formed through the disordered rapid assembly of partially folded pep-
tides, which then reorganize into ordered β sheets. A quantitative analysis (Fig. 4) of the re-
ordering process shows that initially about 60% of the hydrogen bonds within the oligomers
are formed in disordered intermolecular associations, whereas the remainder are involved in
intramolecular interactions within the native α-helix conformation (Fig. 4a). At later stages,
a structural reorganization of the oligomers results in essentially all hydrogen bonds being
involved in the cross-β structure. Thus, in agreement with experimental evidence,31–33 we
5found that the formation of disordered oligomers is primarily driven by hydrophobic ef-
fects, whereas a reorganisation driven by hydrogen bond formation is subsequently playing
a major role in the formation of cross-β structure.16, 26 The formation of ordered assemblies
starts with the pairing of two peptides, from which larger β-sheets develop (Fig. 4b). As
the simulation progresses, the height of the peak in the size distribution function associated
with single β-sheets decreases and multi-layer β sheets form, thus revealing the process of
protofilament formation (Fig. 4c). This observation complements and extends the analysis
shown in Fig. 3, which shows that the β sheets align as they grow in size.
Discussion
Although the presence of disordered aggregates might not always be a prerequisite for amy-
loid fibril formation, these aggregates do seem to appear as intermediate states in many cases,
and indeed it has been suggested that in some cases they may serve as initiation sites for
amyloid fibril growth.34, 35 The simulations that we present provide molecular details of
a sequence-independent mechanism of formation of amyloid-like structures from the ini-
tial disordered aggregates. This mechanism depends on the interplay between hydrophobic
forces that favor an amorphous collapse and hydrogen bonding that favor the formation of
the ordered cross-β structure characteristic of amyloid fibrils. The β-sheets that form within
disordered oligomers tend to align into protofilaments, which then can twist around each
other as their lengths increase. In many protein systems this mechanism will be modulated
by the presence of additional interactions, such as steric repulsions or side chain hydrogen
bonding which are highly sequence specific, but the results that we present show that such
a mechanism can emerge as a generic feature common to polypeptide chains. This phe-
nomenon thus appears to be an example of the Ostwald step rule in first order phase tran-
sitions36 in which the metastable intermediate phase from which nucleation takes place is
represented by the disordered compact and highly dynamical oligomeric assemblies that
form prior to the establishment of the ordered cross-β amyloid structure. The general nature
of this type of mechanism thus provides a rationalisation of the observation that oligomeric
assemblies appear to share common structural features, including those that enable them to
bind to the same antibodies independently from the sequences of their constituent peptides
and proteins.37
In summary, in this work we have investigated the consequences of the generic hypoth-
esis of amyloid formation4 by adopting a model of protein structure specifically designed
to capture the characteristic of polypeptide chains that are common to all peptides and pro-
teins.23 Our results have provided further support to the view that the presence of partially
ordered oligomeric assemblies of the type associated with neurotoxicity constitutes a generic
aspect of the phenomenon of polypeptide aggregation.
6Materials and Methods
Description of the model
The tube model only considers interactions that are common to all polypeptide chains, and
does not include biases towards specific configurations. In the model23 each residue is rep-
resented by a Cα atom. The atoms are connected into a chain (the protein backbone) with a
fixed distance of 3.8A˚ between neighboring atoms. The lines joining the Cα atoms constitute
the axes of hard spherocylinders (cylinders capped by hemispheres) of diameter 4A˚. Sphe-
rocylinders that do not share a Cα atom are not allowed to interpenetrate. Bond angles are
restricted between 82◦ to 148◦, and bending stiffness is introduced by an energetic penalty,
eS, > 0 for angles less than 107.15◦; these are the same criteria used in the original formulation
of the tube model.23 Hydrophobicity enters through a pairwise-additive interaction energy
of eHP (positive or negative) between any pair of residues i and j > i+2 that approach closer
than 7.5A˚.
The cylindrical symmetry of the tube is broken by the presence of hydrogen bonds. A
hydrogen bond has an energy eHB < 0 and is considered to exist between a pair of residues
when the two normal vectors defined by each Cα atom and its two neighbors are mutually
aligned to within 37◦ and at the same time each of these vectors lies within 20◦ of the vector
joining the Cα atoms. These geometrical requirements were deduced from a study of native
protein structures.23 There is also a distance criterion, which is different for local hydrogen
bonds (between residues i and j = i + 3), and non-local (j > i + 4) hydrogen bonds. No
more than two hydrogen bonds per residue are permitted, and the first and last Cα atom
cannot form inter-chain hydrogen bonds. Hydrogen bonds may form cooperatively between
residues (i, j) and (i + 1, j + 1), thereby gaining an additional energy of 0.3eHB. For details
of the distance and angle criteria, the reader is referred to Table 1 of the original article on the
tube model.23
To set the energy scale of the model, the energy of a hydrogen bond is fixed in all simu-
lations at eHB = −3kTo, where kTo is a reference thermal energy and k is Boltzmann’s con-
stant. This value corresponds approximately the energy associated with a hydrogen bond
(1.5kCal/mol at room temperature38). Values of the hydrophobicity and stiffness parameters
eHP and eS are given in units of kTo and the reduced temperature is T ∗ = T/To. In all our
simulations we set eS = 0.9 and eHP = −0.15. The ratio of a hydrogen bonding energy to
hydrophobic energy is a parameter that we set to eHB/eHP = 20, which is a value commonly
used in simulations of the aggregation process.17, 19
Simulation techniques
We performed Monte Carlo simulations in the canonical ensemble using crankshaft, pivot,
reptation, displacement and rotation moves.26 To reduce finite size effects we used a cu-
7bic box and applied periodic boundary conditions. In order to analyze the structure of the
oligomers we used a distance criterion to define a disordered oligomer, which requires two
peptides to have a distance of less than 5 A˚. Two peptide chains are considered to form a β-
sheet if they have more than four inter-chain hydrogen bonds with each other. To define an
angle between different β-sheets we calculated the relative orientation between neighboring
peptides that constitute the different β-sheet. Therefore we require that the centers of mass of
two peptides are separated by less than 10A˚, which is the typical inter-sheet distance in both
native and most amyloid systems.1 To extract the angle we calculate the dot product of the
end to end vectors of the peptide molecules. If the average angle between two β-strands is
less than 20 degree, we assume that the respective β-sheets belong to the same protofilament.
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(a) (b) (c)
Figure 1: Illustration of the self-assembly process of peptides into amyloid-like assemblies.
All simulations were carried out at a concentration c = 12.5 mM and reduced tempera-
ture T ∗ = 0.66. The progress variable t corresponds to the number of Monte Carlo moves
performed in the simulation, and one unit of t is a series of 105 Monte Carlo moves. Ini-
tially, at t = 1000 (left panel), all peptides are in a solvated state. As the simulation pro-
gresses (t = 5000, middle panel) a hydrophobic collapse causes the formation of a disordered
oligomer, which subsequently undergoes a structural reorganization into an amyloid-like as-
sembly (t = 30000, right panel) driven by the formation of ordered arrays of hydrogen bonds.
Peptides that do not form intermolecular hydrogen bonds are shown in blue, while peptides
that form intermolecular hydrogen bonds are assigned a random color, which is the same for
peptides that belong to same β-sheet.
11
0 5000 10000 15000 20000 25000 30000
t
-12
-10
-8
-6
-4
-2
0
En
er
gy
 / 
kT
*
Figure 2: Total energy per peptide as a function of t. Structures formed during the process
of conversion of the disordered oligomer into an amyloid-like structure are also shown at
t = 5000, t = 15000, and t = 30000. The color code is as in Fig. 1.
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Figure 3: Histogram of the numberNn of β-sheets consisting of n peptides at four successive
stages of the growth and reordering process of the oligomeric assembly shown in Fig. 1: (a)
t = 10000, (b) t = 15000, (c) t = 20000, (d) t = 30000). This plot shows how β-sheet assemblies
are progressively formed by the growth and alignment of individual β-sheets. At t = 10000
(a) there are six β-sheets of sizes ranging from 3 to 16, whereas at t = 30000 (d), there are
nine β-sheets of sizes ranging from 8 to 42. If β-sheets are aligned so that the angle between
them is smaller than 20 degrees, they are considered to form a protofilament-like structure,
and the corresponding bars in the histogram are shown with the same color, as for instance
in the case of the red assembly (Fig. 1c right panel), formed by four β-sheets of size 8, 19, 38
and 42.
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Figure 4: Analysis of the evolution of the structure of the oligomers over 11 independent
simulations. (a) Development of the fraction of polypeptide chains in a oligomer (black),
fraction of polypeptide chains in a oligomer that form a β-sheet conformation (blue), frac-
tion of hydrogen bonds in a oligomer in a α-helical conformation (orange), and in a β-sheet
conformation (red), or otherwise (green). (b) Development of the distribution function of the
average number of β–sheets 〈Nn〉 of size n at t = 1000 (black), t = 5000 (red), t = 30000
(blue). (c) Distribution function 〈Nl〉 of the number of protofilaments composed of l layers at
t = 1000(black), t = 15000(red), t = 30000(blue).
